Amgen Shares Dip on Bone Drug Concerns (AP via Yahoo! Finance)
Shares of biotechnology company Amgen Inc. fell Thursday as Wall Street showed concerns over possibly troublesome safety data from a late-stage study of the postmenopausal osteoporosis drug denosumab.